{"ticker": {"uuid": "f57b9547-b36a-4250-a8bc-02cfdccc3edf", "symbol": "688278", "name": "Xiamen Amoytop Biotech Co., Ltd.", "exchange": "SHH", "country": "CN", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Aligos Therapeutics' Shares Rally Following $25M Payment From Xiamen Amoytop Biotech", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOcGlRb2pmajZCNmlUT3ZmbkFSY2Y1UlZvei1mT3ZDaGVQMXB6YTU2dnRuQmV3XzdRejVvTHVVZTA0c09TUmdkNklrNFhkV1prNVJHVkxkMDRnM1BBQVloMDRGZ0Q0b2hGaC1uaG9fQ1BaMUhENEhKbi1vZlZ5OEV4cE1IV29OTWhwYjlEUkNDa0RLS2VIVTFvQ2xwWFlBYXRETWFmaWstZEJvNllOa3V6cWI1NDg4UVE?oc=5", "source_name": "Moomoo", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aligos and Xiamen Amoytop sign deal for HBV therapy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPZi1nTVdUdEJxNHBuZjBUMGt0NHhyOG9IRm40aTRvN05EVzB6dk1mbUN0ZURmZE90UmI5bDRKalNudVRHc1dVV3dwME50bWc4UVpJUmgxZHVVdTV4Zlo4Wms1aDJ6eldmQlplUlVvYzlJU3ZJUHBseTRodnlHZ21TeWoxQmpCVjRMc0xxdzdUSjBSYlZRWGo1WnZyNDNnRUpIenc?oc=5", "source_name": "Market source", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aligos strikes license deal with Amoytop for HBV therapy development", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQRHRYSmQ5WVlDeDlhUWJPWlBmdkREYlVNQUZkeEZEZEUteGN2UHNDOTNpWDRNajJVeHU3dmtQU3FROXAzQVplczJmTElkT0JkWnYtUkpnMWNSM2I1VWtvb0NDRVhlNWRNY3BfUHhrQUdlbDZXdUpXd2N0M0pteE03cHRLM3ZhM1NsN2I1Z0RjdE9abDh2aF80S0pBTEpvMUowenVsOWNfSzhLdVBCcnZCckVR?oc=5", "source_name": "The Pharma Letter", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aligos Therapeutics Enters into Exclusive License Deal with Xiamen Amoytop Biotech Co., Ltd. to Develop and Commercialize Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPWThZSXo0S19oc2VSS2JxUGNjOXRlZXZfYmh6b0tFRm15eG53Y3lDQUhobmlKMjZCVkZucGdFOWYySUxvdEw5UWF0VXVibEptaTF3Z194VnFydHNFdW1rZ0FHQ1NOQlc5dGxsNjhaTEhGdDBqQk5ZYWJOaWswQmhud1BlUGt1NTY4Vk1KNGFhc0hYUkpWVVRweDFYZUhJd3pienNoRm5ybGMta1FkZGY1aWFzZw?oc=5", "source_name": "Market source", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Aligos Therapeutics' Shares Rally Following $25M Payment From Xiamen Amoytop Biotech", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOcGlRb2pmajZCNmlUT3ZmbkFSY2Y1UlZvei1mT3ZDaGVQMXB6YTU2dnRuQmV3XzdRejVvTHVVZTA0c09TUmdkNklrNFhkV1prNVJHVkxkMDRnM1BBQVloMDRGZ0Q0b2hGaC1uaG9fQ1BaMUhENEhKbi1vZlZ5OEV4cE1IV29OTWhwYjlEUkNDa0RLS2VIVTFvQ2xwWFlBYXRETWFmaWstZEJvNllOa3V6cWI1NDg4UVE?oc=5", "source_name": "Moomoo", "published_at": "2026-07-06T07:00:00+00:00", "published_display": "06 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aligos and Xiamen Amoytop sign deal for HBV therapy", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPZi1nTVdUdEJxNHBuZjBUMGt0NHhyOG9IRm40aTRvN05EVzB6dk1mbUN0ZURmZE90UmI5bDRKalNudVRHc1dVV3dwME50bWc4UVpJUmgxZHVVdTV4Zlo4Wms1aDJ6eldmQlplUlVvYzlJU3ZJUHBseTRodnlHZ21TeWoxQmpCVjRMc0xxdzdUSjBSYlZRWGo1WnZyNDNnRUpIenc?oc=5", "source_name": "Market source", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aligos strikes license deal with Amoytop for HBV therapy development", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQRHRYSmQ5WVlDeDlhUWJPWlBmdkREYlVNQUZkeEZEZEUteGN2UHNDOTNpWDRNajJVeHU3dmtQU3FROXAzQVplczJmTElkT0JkWnYtUkpnMWNSM2I1VWtvb0NDRVhlNWRNY3BfUHhrQUdlbDZXdUpXd2N0M0pteE03cHRLM3ZhM1NsN2I1Z0RjdE9abDh2aF80S0pBTEpvMUowenVsOWNfSzhLdVBCcnZCckVR?oc=5", "source_name": "The Pharma Letter", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aligos Therapeutics Enters into Exclusive License Deal with Xiamen Amoytop Biotech Co., Ltd. to Develop and Commercialize Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPWThZSXo0S19oc2VSS2JxUGNjOXRlZXZfYmh6b0tFRm15eG53Y3lDQUhobmlKMjZCVkZucGdFOWYySUxvdEw5UWF0VXVibEptaTF3Z194VnFydHNFdW1rZ0FHQ1NOQlc5dGxsNjhaTEhGdDBqQk5ZYWJOaWswQmhud1BlUGt1NTY4Vk1KNGFhc0hYUkpWVVRweDFYZUhJd3pienNoRm5ybGMta1FkZGY1aWFzZw?oc=5", "source_name": "Market source", "published_at": "2026-04-16T07:00:00+00:00", "published_display": "16 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 59, "total_relevant": 5, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 5, "score": 50, "total": 5, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "deals", "primary_label": "Deals and strategy", "confidence": 66, "events": [{"event": "deals", "label": "Deals and strategy", "weight": 1.65, "count": 3}, {"event": "general", "label": "Market update", "weight": 1.45, "count": 2}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 57.53, "latest_week": "2026-07-17", "one_week_move": 3.3, "four_week_move": 3.1, "twelve_week_move": -0.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.292865, "market_dynamics_buy_signal": false, "relative_strength": -16.018096, "fair_value_gap": -9.2, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 48.6545, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+3.3% over one week, +3.1% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 53, "badges": [], "opportunities": [], "risks": [], "event_label": "Deals and strategy", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 2}, {"label": "Moomoo", "count": 1}, {"label": "The Pharma Letter", "count": 1}, {"label": "Barron's", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 5}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Deals and strategy", "count": 3}, {"label": "Market update", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Deals and strategy", "tone": "neutral", "text": "66/100 classification confidence."}, {"label": "Company focus", "value": "5", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+3.3% over one week, +3.1% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Aligos Therapeutics' Shares Rally Following $25M Payment From Xiamen Amoytop Biotech"}], "updated_at": "2026-07-22T04:02:43.985592+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}